Arkolith/Insider Trading/BIAF/Form 4

Zannes Maria

President, CEO, DirectorbioAffinity Technologies, Inc. (BIAF) · full profile →Form 4 · filed Nov 22, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
3 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2022Grant(A)18K—$062K
Sep 6, 2022Conversion(C)24K$4.20$99K44K
Aug 31, 2022Buy(P)16K——20K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 6, 2022Grant(A)0——24K
Sep 6, 2022Conversion(C)24K—$00
Aug 31, 2022Buy(P)16K——16K
Aug 31, 2022Buy(P)16K——16K

Transaction Codes

A
Grant / award
C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-033283) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML